William Hinshaw

William Hinshaw (chief executive) discloses dealings in Axcella Health Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 28 January 2022 to 17 October 2022.

Purchases make up the whole of the open-market record (1 purchase, €23k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 1 option exercise.

Most recently, on 19 October 2022, the filings show a share grant in Axcella Health Inc. The latest purchase dates back some time: it was published 1,675 days ago, on 18 March 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.